Redx gets UK regulator backing to re-start phase 1/2a clinical study for Porcupine inhibitor

Image: Redx has presented an amended study protocol to the Medicines and Healthcare products Regulatory Agency. Photo: courtesy of Jan Friml / FreeImages.